Pediatr. praxi. 2009;10(6):382-384
The neonatal withdrawal syndrome and its therapy
- Pediatrická klinika 2. LF UK a FN Motol, Praha
The authors describe neonatal withdrawal syndrome (NWS), its symptoms, therapy and potential complications for the foetus during
pregnancy as a consequence of drug-addicted mother. NWS occurs in newborns exposed to opioids, stimulans, canabinoids and other
drugs, the wide range of signs of NWS is an impact of withdrawal on both central and vegetative nervous systems, gastrointestinal system
and respiratory system. For the evaluation of symptoms and seriousness of NWS the Finnegan score is used worldwide; the Finnegan
score higher than 8 points is an indication to start substitutive therapy. A long-term therapy of NWS is necessary very often. There is an
evidence of better outcome for patients, whose mothers undergo substitutive therapy during the pregnancy.
Keywords: drugs in pregnancy, neonatal withdrawal syndrome, Finnegan score, substitutive therapy
Published: January 1, 2010 Show citation
References
- Vavřinková B, Binder T. Návykové látky v těhotenství. Zaostřeno na drogy 2007; 5(4): 1-12.
- Výroční zpráva ČR - 2007: Incidence, prevalence, zdravotní dopady a trendy léčených uživatelů drog. Hygienická stanice Hl. m. Prahy, Centrální pracoviště drogové epidemiologie, Praha 2008.
- Fišárková B, Tkaczyk J. Novorozenec drogově závislé matky - zásady postnatální péče. Neonatologické listy 2008; 14(2): 11-14.
- Bada HS, Das A, et al. Low birth weight and preterm births; etiologic fraction attributable to prenatal drug exposure. J Perinatol. 2006; 26: 11-14.
Go to PubMed... - Bishai R, Koren G. Maternal and obstetric effects of prenatal drug exposure. Clin Perinatol. 1999; 26(1): 75-106.
Go to original source... Go to PubMed... - Forrester MB, Merz RD. Risk of selected birth defects with prenatal illicit drug use, Hawaii, 1986-2002. J Toxicol Environ Health A. 2007; 70: 7-18. Go to original source... Go to PubMed...
- American Academy of Pediatrics Commitee on Drugs. Neonatal drug withdrawal. Pediatrics 1998; 101: 1079-1088. Go to original source...
- Kassima Z, Greenough A. Neonatal abstinence syndrome: Identification and management. Current Paediatrics 2006; 16: 172-175. Go to original source...
- Finnegan LP. Prenatal drug exposure. In: Clinical manual of substance abuse. Second ed. Philadelphia: Mosby. 1996: 257-271.
- Finnegan LP. Neonatal abstinence syndrome: assessment and pharmacolotherapy. In: Neonatal therapy: An update. New York, NY: Excerpta Medica; 1986: 122-146.
- Jansson LM, Choo R, et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics 2008; 121: 106-114. Go to original source... Go to PubMed...
- Johnson K, Gerada C, Greenough A. Treatment of neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed. 2003; 88(1): F2-5. Go to original source... Go to PubMed...
- Oei J, Lui K. Management of the newborn infant affected by maternal opiates and other drugs of dependency. J Paediatr Child Health. 2007; 43(1-2): 9-18. Go to original source... Go to PubMed...
- Van Baar A, de Graaf BMT. Cognitive development and preschool-age of infants of drug - dependent mothers. Dev Med Child Neurol. 1994; 36: 1063-1075. Go to original source... Go to PubMed...
- Vance JC, Chant DC, Tudehope DI, et al. Infants born to narcotic dependent mothers: physical growth patterns in the first 12 months of life. J Paediatr Child Health 1997; 33(6): 504-508. Go to original source... Go to PubMed...